Does Somatostatin Confer Insulinostatic Effects of Neuromedin U in the Rat Pancreas?
The DOI matches its Crossref record; 20 of the 21 references it cites were found in a registry or an index.
Abstract
OBJECTIVES: Neuromedin U (NmU) is a neuropeptide with anorexigenic activity. Two receptor subtypes (NmUR1 and NmUR2) confer the effects of NmU on target cells. We have recently demonstrated that NmU reduces insulin secretion from isolated pancreatic islets. Aim of our current study is to investigate the role of somatostatin at mediating the effects of NmU on insulin secretion. METHODS: Expression of NmU in the pancreas was detected by immunohistochemistry. Insulin and somatostatin secretion from in situ perfused rat pancreas and isolated pancreatic islets was measured by radioimmunoassay. The paracrine effects of somatostatin within pancreatic islets were blocked by cyclosomatostatin, a somatostatin receptor antagonist. RESULTS: Receptor subtype NmUR1, but not NmUR2, was expressed in the endocrine pancreas, predominantly in the periphery. Neuromedin U reduced insulin secretion from in situ perfused rat pancreas and stimulated somatostatin secretion from isolated pancreatic islets. Neuromedin U stimulated somatostatin secretion at both physiological and supraphysiological glucose concentrations. Cyclosomatostatin increased insulin secretion and reduced NmU-induced inhibition of insulin secretion. CONCLUSIONS: Neuromedin U reduces insulin and increases somatostatin secretion. Blockade of somatostatin action abolishes the inhibition of insulin secretion by NmU. The results of the study suggest that somatostatin mediates the inhibitory action of NmU on insulin secretion.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The underlying mechanism involves the simultaneous release of somatostatin—a known modulator of insulin secretion6—upon NmUR1 activation.232”
From Pancreatic regulation of glucose homeostasis. (2016) · cites this paper as [232]
Citations
Cites
Obesity and insulin resistance
Kahn, B. B., & Flier, J. S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10842 · Cited by 3,225
Method for the Isolation of Intact Islets of Langerhans from the Rat Pancreas
Lacy, P. E., & Kostianovsky, M. (1967) · Diabetes · doi:10.2337/diab.16.1.35 · Cited by 2,751
Identification of receptors for neuromedin U and its role in feeding
Howard, A. D., Wang, R., Pong, S.-S., Mellin, T. N., Strack, A., Guan, X.-M., Zeng, Z., Williams, D. L., Feighner, S. D., Nunes, C. N., et al. (2000) · Nature · doi:10.1038/35017610 · Cited by 415
Minamino, N., Kangawa, K., & Matsuo, H. (1985) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(85)91726-7 · Cited by 301
Neuromedin U has a novel anorexigenic effect independent of the leptin signaling pathway
Hanada, R., Teranishi, H., Pearson, J. T., Kurokawa, M., Hosoda, H., Fukushima, N., Fukue, Y., Serino, R., Fujihara, H., Ueta, Y., et al. (2004) · Nature Medicine · doi:10.1038/nm1106 · Cited by 209
Identification of Neuromedin U as the Cognate Ligand of the Orphan G Protein-coupled Receptor FM-3
Fujii, R., Hosoya, M., Fukusumi, S., Kawamata, Y., Habata, Y., Hinuma, S., Onda, H., Nishimura, O., & Fujino, M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001546200 · Cited by 204
Raddatz, R., Wilson, A. E., Artymyshyn, R., Bonini, J. A., Borowsky, B., Boteju, L. W., Zhou, S., Kouranova, E. V., Nagorny, R., Guevarra, M. S., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004613200 · Cited by 202
Mechanisms of inhibition of insulin release
Sharp, G. W. (1996) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1996.271.6.c1781 · Cited by 198
Neuromedin U Is a Potent Agonist at the Orphan G Protein-coupled Receptor FM3
Szekeres, P. G., Muir, A. I., Spinage, L. D., Miller, J. E., Butler, S. I., Smith, A., Rennie, G. I., Murdock, P. R., Fitzgerald, L. R., Wu, H.-L., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000244200 · Cited by 179
Central Effects of Neuromedin U in the Regulation of Energy Homeostasis
Nakazato, M., Hanada, R., Murakami, N., Date, Y., Mondal, M. S., Kojima, M., Yoshimatsu, H., Kangawa, K., & Matsukura, S. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3669 · Cited by 179
Cited by
Pancreatic regulation of glucose homeostasis.
Röder, P. V., Wu, B., Liu, Y., & Han, W. (2016) · Experimental & Molecular Medicine · doi:10.1038/emm.2016.6 · Cited by 985
An atlas and functional analysis of G-protein coupled receptors in human islets of Langerhans
Amisten, S., Salehi, A., Rorsman, P., Jones, P. M., & Persaud, S. J. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.05.004 · Cited by 196
Neuromedin U: A Multifunctional Neuropeptide with Pleiotropic Roles
Martinez, V. G., & O'Driscoll, L. (2015) · Clinical Chemistry · doi:10.1373/clinchem.2014.231753 · Cited by 131
Effects of Peripherally Administered Neuromedin U on Energy and Glucose Homeostasis
Peier, A. M., Desai, K., Hubert, J. A., Du, X., Yang, L., Qian, Y., Kosinski, J. R., Metzger, J. M., Pocai, A., Nawrocki, A. R., et al. (2011) · Endocrinology · doi:10.1210/en.2010-1463 · Cited by 79
Neuromedins NMU and NMS: An Updated Overview of Their Functions
Malendowicz, L. K., & Ruciński, M. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.713961 · Cited by 55
Self-citationNeuromedin U suppresses glucose-stimulated insulin secretion in pancreatic β cells
Zhang, W., Sakoda, H., Miura, A., Shimizu, K., Mori, K., Miyazato, M., Takayama, K., Hayashi, Y., & Nakazato, M. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.08.132 · Cited by 26
Small lipidated anti-obesity compounds derived from neuromedin U
Micewicz, E. D., Bahattab, O. S., Willars, G. B., Waring, A. J., Navab, M., Whitelegge, J. P., McBride, W. H., & Ruchala, P. P. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.07.020 · Cited by 24
Jarry, A., Merah, N., Cisse, F., Cayetanot, F., Fiamma, M., Willemetz, A., Gueddouri, D., Barka, B., Valet, P., Guilmeau, S., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201801718r · Cited by 24
Neuromedin U Does Not Act as a Decretin in Rats
Kuhre, R. E., Christiansen, C. B., Ghiasi, S. M., Gabe, M. B. N., Skat-Rørdam, P. A., Modvig, I. M., Mandrup-Poulsen, T. R., Albrechtsen, R., ROSENKILDE, M. M., Hartmann, B., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.10.008 · Cited by 15
Current Approaches in Diabetes Treatment and Other Strategies to Reach Normoglycemia
Sirhan, W., & Piran, R. (2020) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026620666200716113813 · Cited by 13
Regulation of feeding and therapeutic application of bioactive peptides
Ueno, H., Zhang, W., & Nakazato, M. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108187 · Cited by 7
Ensho, T., Maruyama, K., Qattali, A. W., Yasuda, M., Uemura, R., Murakami, N., & Nakahara, K. (2019) · Journal of Veterinary Medical Science · doi:10.1292/jvms.19-0320 · Cited by 5
Signalling, Desensitization and Resensitization of Neuromedin U Receptors
Alhosaini, K. A. (2011) · OpenGrey (Institut de l'Information Scientifique et Technique) · Cited by 3
The entero-insular axis: a journey in the physiopathology of diabetes
Malaguarnera, R., Scamporrino, A., Filippello, A., Mauro, S. D., Minardo, A., Purrello, F., & Piro, S. (2020) · Exploration of Medicine · doi:10.37349/emed.2020.00025 · Cited by 2
Neuromedin U receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database
Alhosaini, K. A., Bloom, S. R., Hedrick, J. A., Howard, A. D., Jethwa, P. H., Luckman, S. M., Raddatz, R., Semjonous, N. M., & Willars, G. B. (2019) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f42/2019.4 · Cited by 2
Malendowicz, L. K., Ruciński, M., & Ziółkowska, A. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-385095-9.00135-4 · Cited by 2
Self-citationLa signalisation insuline comme garant de la fonction barrière intestinale
Gueddouri, D. (2021) · theses.fr (ABES) · doi:10.70675/8371f5a7zb0c3z4f82z83e9z236d0eedb3f1
BindingDB Entry 50006544: Small lipidated anti-obesity compounds derived from neuromedin U.
BindingDB (2020) · UC San Diego · doi:10.7270/q26h4mff
The role of ligand processing in neuromedin U receptor signalling and regulation
Bahattab, O. S. (2016) · Figshare
ニューロメジンU受容体をターゲットとした抗肥満薬開発における薬理学的研究
Kaisho, T. (2018) · Institutional Repositories DataBase (IRDB)
Metadata
- Authors
- Kaczmarek, P., Malendowicz, L. K., Fabis, M., Ziolkowska, A., Pruszynska-Oszmalek, E., Sassek, M., Wojciechowicz, T., Szczepankiewicz, D., Andralojc, K., Szkudelski, T., Strowski, M. Z., & Nowak, K. W.
- Affiliations
- Poznan University of Medical Sciences (PL)
- Thomas Jefferson University (US)
- Charité – Universitätsmedizin Berlin (DE)
- Corresponding author
- Fabis, Marzena
- Sassek, Maciej
- Wojciechowicz, Tatiana
- Szczepankiewicz, Dawid
- Andralojc, Karolina
- Szkudelski, Tomasz
- Nowak, Krzysztof W.
- ORCID
- Venue
- Pancreas
- Published
- 2009-03
- Volume
- 38
- Issue
- 2
- Pages
- 208-212
- ISSN
- 0885-3177 (ISSN-L)
- OpenAlex
- W2020733318
- Cited by
- 18
- References
- 21
- Citations by year
- 2022: 1 · 2021: 2 · 2020: 2 · 2019: 3 · 2018: 2 · 2017: 1 · 2016: 1 · 2015: 2 · 2013: 2
- FWCI
- 0.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Pancreas (publishedVersion)
- PubMed (publishedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- neuromedin U, somatostatin, insulin secretion, pancreatic islets, paracrine signaling, endocrine pancreas, glucose-stimulated insulin secretion, anorexigenic peptides
- MeSH terms
- Insulin Secretion, Animals, Insulin, Neuropeptides, Pancreas, Somatostatin, Rats, Wistar, Receptors, Neurotransmitter, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.